Biểu đồ giá cổ phiếu ASMB
ASMB Cổ tức
Assembly Biosciences Inc
$28.34
6.94%
$1.83
Khi đóng cửa: May 22, 16:00:00 GMT-4
$27.99
-1.23%
$-0.35
Phiên sau giờ: May 22, 20:00:00 GMT-4
Quay lại
Assembly Biosciences Inc (ASMB) Cổ tức
Thống kê chính
Giá đóng cửa trước
$26.5
Giá mở cửa
$28.61
Phạm vi ngày
$27.79 - $31.89
Phạm vi 52 tuần
$11.64 - $39.7
Khối lượng
888.2K
Khối lượng trung bình
105.2K
Tỷ suất cổ tức
--
EPS (TTM)
-1.93
Vốn hóa thị trường
$443.9M
ASMB là gì?
Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. The company is headquartered in South San Francisco, California and currently employs 73 full-time employees. The company went IPO on 2010-12-17. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. The company is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).
